Scinai Immunotherapeutics (SCNI) Competitors $2.06 -0.08 (-3.74%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$2.13 +0.07 (+3.40%) As of 07/25/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock SCNI vs. GNPX, XFOR, BMRA, APM, ADXN, CHRO, BFRI, TLPH, TSBX, and ARTLShould you be buying Scinai Immunotherapeutics stock or one of its competitors? The main competitors of Scinai Immunotherapeutics include GENPREX (GNPX), X4 Pharmaceuticals (XFOR), Biomerica (BMRA), Aptorum Group (APM), Addex Therapeutics (ADXN), Chromocell Therapeutics (CHRO), Biofrontera (BFRI), Talphera (TLPH), Turnstone Biologics (TSBX), and Artelo Biosciences (ARTL). These companies are all part of the "pharmaceutical products" industry. Scinai Immunotherapeutics vs. Its Competitors GENPREX X4 Pharmaceuticals Biomerica Aptorum Group Addex Therapeutics Chromocell Therapeutics Biofrontera Talphera Turnstone Biologics Artelo Biosciences Scinai Immunotherapeutics (NASDAQ:SCNI) and Genprex (NASDAQ:GNPX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation. Does the media prefer SCNI or GNPX? In the previous week, Scinai Immunotherapeutics and Scinai Immunotherapeutics both had 1 articles in the media. Genprex's average media sentiment score of 1.89 beat Scinai Immunotherapeutics' score of 1.87 indicating that Genprex is being referred to more favorably in the news media. Company Overall Sentiment Scinai Immunotherapeutics Very Positive Genprex Very Positive Do insiders & institutionals hold more shares of SCNI or GNPX? 58.4% of Scinai Immunotherapeutics shares are held by institutional investors. Comparatively, 14.1% of Genprex shares are held by institutional investors. 60.9% of Scinai Immunotherapeutics shares are held by insiders. Comparatively, 8.5% of Genprex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, SCNI or GNPX? Scinai Immunotherapeutics has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500. Comparatively, Genprex has a beta of -0.5, indicating that its stock price is 150% less volatile than the S&P 500. Which has stronger valuation & earnings, SCNI or GNPX? Scinai Immunotherapeutics has higher revenue and earnings than Genprex. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioScinai Immunotherapeutics$660K3.12$4.80M-$9.57-0.22GenprexN/AN/A-$21.11MN/AN/A Is SCNI or GNPX more profitable? Scinai Immunotherapeutics' return on equity of 0.00% beat Genprex's return on equity.Company Net Margins Return on Equity Return on Assets Scinai ImmunotherapeuticsN/A N/A -40.60% Genprex N/A -664.65%-370.18% SummaryScinai Immunotherapeutics beats Genprex on 7 of the 8 factors compared between the two stocks. Get Scinai Immunotherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCNI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNI vs. The Competition Export to ExcelMetricScinai ImmunotherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.14M$3.06B$5.69B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio-0.2221.1828.1020.05Price / Sales3.12288.50432.4490.07Price / CashN/A42.7636.2258.56Price / Book0.408.378.665.87Net Income$4.80M-$55.19M$3.25B$258.55M7 Day Performance-4.19%5.88%4.23%3.74%1 Month Performance-16.60%17.33%10.52%11.75%1 Year Performance-52.75%4.42%34.41%18.03% Scinai Immunotherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNIScinai Immunotherapeutics1.7577 of 5 stars$2.06-3.7%N/A-45.4%$2.14M$660K-0.2220GNPXGENPREX1.3321 of 5 stars$0.27+0.7%N/A-85.9%$9.05MN/A0.0020Positive NewsXFORX4 Pharmaceuticals4.9383 of 5 stars$1.50+0.3%$72.33+4,738.4%-93.0%$8.85M$2.56M0.7180Positive NewsBMRABiomerica1.2758 of 5 stars$3.48-3.5%N/A+39.9%$8.84M$5.41M-1.4960APMAptorum Group1.6295 of 5 stars$1.60-0.7%N/A-48.3%$8.77MN/A0.0030News CoverageUpcoming EarningsADXNAddex Therapeutics2.5098 of 5 stars$8.27+5.6%$30.00+263.0%+3.2%$8.73M$170.62K-24.2430Positive NewsCHROChromocell TherapeuticsN/A$1.34+6.3%N/A-89.3%$8.69MN/A-1.084Gap UpHigh Trading VolumeBFRIBiofrontera3.0507 of 5 stars$0.91+0.4%$2.75+203.9%-3.6%$8.68M$37.32M-0.4170Gap UpTLPHTalphera2.7082 of 5 stars$0.41+2.8%$5.00+1,116.5%-50.5%$8.49M$650K-0.9219TSBXTurnstone Biologics3.4257 of 5 stars$0.36+0.1%$0.45+26.4%-85.7%$8.40M$19.31M-0.1382ARTLArtelo Biosciences3.0512 of 5 stars$14.74+1.3%$25.00+69.6%+64.6%$7.96MN/A-0.795 Related Companies and Tools Related Companies GENPREX Alternatives X4 Pharmaceuticals Alternatives Biomerica Alternatives Aptorum Group Alternatives Addex Therapeutics Alternatives Chromocell Therapeutics Alternatives Biofrontera Alternatives Talphera Alternatives Turnstone Biologics Alternatives Artelo Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCNI) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scinai Immunotherapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Scinai Immunotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SCNI Stock Alerts